PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 11327082-0 2001 Prostaglandin F2alpha upregulates interleukin-6 production in human gingival fibroblasts. Dinoprost 0-21 interleukin 6 Homo sapiens 34-47 30827352-11 2019 PGF2alpha increased mRNA content and protein activity of MMP9, and gene and protein expression of interleukin-6 (P < 0.05). Dinoprost 0-9 interleukin 6 Homo sapiens 98-111 25882540-4 2015 Confirmatory enzyme-linked immunosorbent assays (ELISAs) showed that PGF2alpha stimulated increased output of interleukin (IL) 1beta, IL6, IL8 (CXCL8) and monocyte chemotactic protein-1 (MCP1, also known as chemokine (c-c motif) ligand 2, CCL2) by HUSMCs isolated from both upper and lower uterine segments. Dinoprost 69-78 interleukin 6 Homo sapiens 134-137 25882540-10 2015 Inhibition of ERK reversed PGF2alpha-induced IL1beta, IL6 and CCL2 output, while inhibition of PI3K blocked the effect of PGF2alpha on IL6, CXCL8 and CCL2 output and inhibition of NF-kappaB reversed PGF2alpha-induced IL1beta and CCL2 output. Dinoprost 27-36 interleukin 6 Homo sapiens 54-57 25882540-10 2015 Inhibition of ERK reversed PGF2alpha-induced IL1beta, IL6 and CCL2 output, while inhibition of PI3K blocked the effect of PGF2alpha on IL6, CXCL8 and CCL2 output and inhibition of NF-kappaB reversed PGF2alpha-induced IL1beta and CCL2 output. Dinoprost 122-131 interleukin 6 Homo sapiens 135-138 25882540-10 2015 Inhibition of ERK reversed PGF2alpha-induced IL1beta, IL6 and CCL2 output, while inhibition of PI3K blocked the effect of PGF2alpha on IL6, CXCL8 and CCL2 output and inhibition of NF-kappaB reversed PGF2alpha-induced IL1beta and CCL2 output. Dinoprost 122-131 interleukin 6 Homo sapiens 135-138 11327082-9 2001 TMB-8 significantly suppressed PGF2alpha-induced IL-6 production, whereas calphostin C showed a stimulatory effect on PGF2alpha-induced IL-6 production. Dinoprost 118-127 interleukin 6 Homo sapiens 136-140 11327082-10 2001 From these data, we suggest that PGF2alpha upregulates IL-6 production through FP receptors in HGF, that PGF2alpha synergistically enhances IL-6 production in IL-1beta- and TNFalpha-stimulated HGF, and that PGF2alpha-induced IL-6 production may be dependent on intracellular Ca2+ mobilization and be downregulated by PKC activation. Dinoprost 33-42 interleukin 6 Homo sapiens 55-59 11327082-10 2001 From these data, we suggest that PGF2alpha upregulates IL-6 production through FP receptors in HGF, that PGF2alpha synergistically enhances IL-6 production in IL-1beta- and TNFalpha-stimulated HGF, and that PGF2alpha-induced IL-6 production may be dependent on intracellular Ca2+ mobilization and be downregulated by PKC activation. Dinoprost 105-114 interleukin 6 Homo sapiens 140-144 11327082-10 2001 From these data, we suggest that PGF2alpha upregulates IL-6 production through FP receptors in HGF, that PGF2alpha synergistically enhances IL-6 production in IL-1beta- and TNFalpha-stimulated HGF, and that PGF2alpha-induced IL-6 production may be dependent on intracellular Ca2+ mobilization and be downregulated by PKC activation. Dinoprost 105-114 interleukin 6 Homo sapiens 140-144 11327082-10 2001 From these data, we suggest that PGF2alpha upregulates IL-6 production through FP receptors in HGF, that PGF2alpha synergistically enhances IL-6 production in IL-1beta- and TNFalpha-stimulated HGF, and that PGF2alpha-induced IL-6 production may be dependent on intracellular Ca2+ mobilization and be downregulated by PKC activation. Dinoprost 105-114 interleukin 6 Homo sapiens 140-144 11327082-10 2001 From these data, we suggest that PGF2alpha upregulates IL-6 production through FP receptors in HGF, that PGF2alpha synergistically enhances IL-6 production in IL-1beta- and TNFalpha-stimulated HGF, and that PGF2alpha-induced IL-6 production may be dependent on intracellular Ca2+ mobilization and be downregulated by PKC activation. Dinoprost 105-114 interleukin 6 Homo sapiens 140-144 11327082-11 2001 PGF2alpha may be involved in the pathogenesis of periodontal disease by enhancing IL-6 levels in periodontal lesions. Dinoprost 0-9 interleukin 6 Homo sapiens 82-86 30794283-0 2019 Cooperative effects of sequential PGF2alpha and IL-1beta on IL-6 and COX-2 expression in human myometrial cells . Dinoprost 34-43 interleukin 6 Homo sapiens 60-64 30794283-5 2019 Sequential stimulation of HMSMC by PGF2alpha and IL-1beta in either order results in amplified upregulation of IL-6 and COX-2 mRNA and protein, compared to their effects individually. Dinoprost 35-44 interleukin 6 Homo sapiens 111-115 30794283-7 2019 These results suggest that PGF2alpha and IL-1beta act cooperatively upstream in the birth cascade to maximize amplification of IL-6 and COX-2, to build inflammatory load and thereby promote uterine transition. Dinoprost 27-36 interleukin 6 Homo sapiens 127-131 30794283-8 2019 Targeting PGF2alpha or IL-1beta, their actions, or intermediates (e.g. IL-6) would be an effective therapeutic intervention for preterm birth prevention or delay. Dinoprost 10-19 interleukin 6 Homo sapiens 71-75 11327082-4 2001 PGF2alpha stimulated IL-6 production in a time- and concentration-dependent fashion. Dinoprost 0-9 interleukin 6 Homo sapiens 21-25 11327082-5 2001 IL-1beta and tumor necrosis factor alpha (TNFalpha), proinflammatory cytokines, induced IL-6 production in a time-dependent manner, and PGF2alpha synergistically enhanced IL-6 production induced by IL-1beta and TNFalpha. Dinoprost 136-145 interleukin 6 Homo sapiens 171-175 11327082-6 2001 IL-6 mRNA was expressed in PGF2alpha-stimulated HGF, and PGF2alpha increased IL-6 mRNA levels induced by IL-1beta and TNFalpha. Dinoprost 27-36 interleukin 6 Homo sapiens 0-4 11327082-6 2001 IL-6 mRNA was expressed in PGF2alpha-stimulated HGF, and PGF2alpha increased IL-6 mRNA levels induced by IL-1beta and TNFalpha. Dinoprost 57-66 interleukin 6 Homo sapiens 77-81 11327082-7 2001 Fluprostenol, a selective FP receptor agonist, could mimic PGF2alpha-induced IL-6 production. Dinoprost 59-68 interleukin 6 Homo sapiens 77-81 11327082-8 2001 Since FP receptors are coupled to elevation of intracellular calcium and activation of protein kinase C (PKC), the mechanism of IL-6 production by PGF2alpha was investigated using TMB-8, an inhibitor of Ca2+ mobilization from intracellular stores, and calphostin C, an inhibitor of PKC. Dinoprost 147-156 interleukin 6 Homo sapiens 128-132 11327082-9 2001 TMB-8 significantly suppressed PGF2alpha-induced IL-6 production, whereas calphostin C showed a stimulatory effect on PGF2alpha-induced IL-6 production. Dinoprost 31-40 interleukin 6 Homo sapiens 49-53 2107353-7 1990 However, when PDGF-BB or -AB was combined with IL-1 beta or IL-6, prostanoid generation by HMC was synergistically increased up to 222-fold (IL-1 beta) or 12-fold (IL-6) above the control values, with the induction of PGE2 greater than 6-keto-PGF1 alpha greater than PGF2 alpha much greater than TXB2. Dinoprost 267-271 interleukin 6 Homo sapiens 60-64 9581864-2 1998 In the present study, we investigated the effect of tiludronate, a bisphosphonate known to inhibit bone resorption, on the PGF2alpha- and PGE1-induced IL-6 synthesis in these cells. Dinoprost 123-132 interleukin 6 Homo sapiens 151-155 9581864-10 1998 These results strongly suggest that tiludronate inhibits PGF2alpha-induced IL-6 synthesis via suppression of phosphatidylcholine-hydrolyzing phospholipase D activation in osteoblasts, and that the inhibitory effect is exerted at the point between heterotrimeric GTP-binding protein and phospholipase D. Dinoprost 57-66 interleukin 6 Homo sapiens 75-79